Avalon Leads $18M in Early Funding for Cancer Immunotherapy Startup
Xconomy
SEPTEMBER 27, 2016
Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups).
Let's personalize your content